BIA 2-093

Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization

A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate

Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine

Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers

The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin

A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093

Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites

The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093

A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093

Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers

An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093

Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate

Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and Carbamazepine

Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate

Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers

A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093

Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093

An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093

Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.

Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function